pentoxifylline has been researched along with Lassitude in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " It is showed that the use of 100 mg of ladasten, 16 mg of ondansetron orally per day and 50 mg of agomelatine per night is more effective in therapy for fatigue/weakness syndrome in incurable cancer patients compared to standard therapy." | 5.20 | [Optimization of pharmacological therapy for weakness syndrome in incurable patients]. ( Glushchenko, VA; Karitsky, AP; Kvashnin, AV; Rozengard, SA; Ryazankina, AA, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ryazankina, AA | 1 |
| Rozengard, SA | 1 |
| Glushchenko, VA | 1 |
| Karitsky, AP | 1 |
| Kvashnin, AV | 1 |
| Tuckey, JA | 1 |
| Parry, BR | 1 |
| McCall, JL | 1 |
| Burks, TF | 1 |
1 review available for pentoxifylline and Lassitude
| Article | Year |
|---|---|
New agents for the treatment of cancer-related fatigue.
Topics: alpha-MSH; Anti-Inflammatory Agents, Non-Steroidal; Bradykinin; Cyclooxygenase 1; Cyclooxygenase 2; | 2001 |
2 trials available for pentoxifylline and Lassitude
| Article | Year |
|---|---|
[Optimization of pharmacological therapy for weakness syndrome in incurable patients].
Topics: Acetamides; Adamantane; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Ant | 2015 |
Pentoxifylline and wellbeing in cancer.
Topics: Colorectal Neoplasms; Fatigue; Gastrointestinal Neoplasms; Humans; Pentoxifylline; Quality of Life; | 1993 |